- Pope ZC, Weisend CM, Shah A, Ebihara H, Rizza SA. Inactivation of replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on common surfaces by disinfectants. Infect Control Hosp Epidemiol. 26:1-3. 2022
- Kirino Y, Yamamoto S, Nomachi T, Ngan MT, Sato Y, Sudaryatma PE, Norimine J, Fujii Y, Ando S, Okabayashi T. Serological and molecular survey of tick borne pathogens, severe fever with thrombocytopenia syndrome virus, spotted fever group rickettsiae, and Orientia tsutsugamushi, in wild boars (Sus scrofa) in Miyazaki prefecture, Japan. Veterinary Medicine and Science, 8: 877-885, 2022
- Oshima H, Okumura H, Maeda K, Ishijima K, Yoshikawa T, Kurosu T, Fukushi S, Shimojima M, Saijo M. 2022. A Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected from a Sick Dog with SFTS Virus Infection. Jpn J Infect Dis 75(4):423-426, 2022.
- Miyamoto S, Arashiro T, Adachi Y, Moriyama S, Kinoshita H, Kanno T, Saito S, Katano H, Iida S, Ainai A, Kotaki R, Yamada S, Kuroda Y, Yamamoto T, Ishijima K, Park ES, Inoue Y, Kaku Y, Tobiume M, Iwata-Yoshikawa N, Shiwa-Sudo N, Tokunaga K, Ozono S, Hemmi T, Ueno A, Kishida N, Watanabe S, Nojima K, Seki Y, Mizukami T, Hasegawa H, Ebihara H, Maeda K, Fukushi S, Takahashi Y, Suzuki T. Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants. Med (N Y). 3(4):249-261.e4. 2022
- Lombe BP, Miyamoto H, Saito T, Yoshida R, Manzoor R, Kajihara M, Shimojima M, Fukushi S, Morikawa S, Yoshikawa T, Kurosu T, Saijo M, Tang Q, Masumu J, Hawman D, Feldmann H, Takada A. Purification of Crimean-Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis. Sci Rep. 11(1):2324. 2022
- Shibamura M, Yamada S, Yoshikawa T, Inagaki T, Nguyen PHA, Fujii H, Harada S, Fukushi S, Oka A, Mizuguchi M, Saijo M. Longitudinal trends of neutralizing antibody prevalence against human cytomegalovirus (HCMV) over the past 30 years in Japanese women. Jpn J Infect Dis. Apr 28. doi: 10.7883/yoken.JJID.2021.726. 2022
- Takamatsu Y, Yoshikawa T, Kurosu T, Fukushi S, Nagata N, Shimojima M, Ebihara H, Saijo M, Noda T. 2022. Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport. J Virol 2022, 96(17):e0108322
- Fujii H, Tani H, Egawa K, Taniguchi S, Yoshikawa T, Fukushi S, Yamada S, Harada S, Kurosu T, Shimojima M, Maeki T, Lim CK, Takayama-Ito M, Komeno T, Nakajima N, Furuta Y, Uda A, Morikawa S, Saijo M. 2022. Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV. Viruses 2022, 14(8):1668
- Shimojima M, Sugimoto S, Umekita K, Onodera T, Kaori S, Tani H, Takamatsu Y, Yoshikawa T, Kurosu T, Suzuki T, Takahashi Y, Ebihara H, Saijo M. Neutralizing mAbs against SFTS virus Gn protein show strong therapeutic effects in an SFTS animal model. Viruses 2022, 14(8), 1665.
- Miyake A, Ngo MH, Wulandari S, Shimojima M, Nakagawa S, Kawasaki J, Nishigaki K. Convergent evolution of antiviral machinery derived from endogenous retrovirus truncated envelope genes in multiple species. Proc Natl Acad Sci U S A. 2022;119(26):e2114441119.
- Taniguchi S, Inagaki T, Tajima S, Suzuki T, Yoshikawa T, Fukushi S, Park ES, Fujii H, Morikawa S, Tani H, Nakayama E, Maeki T, Shimojima M, Lim CK, Saijo M. Reverse Genetics System for Heartland Bandavirus: NSs Protein Contributes to Heartland Bandavirus Virulence. J Virol. 2022;96(7):e0004922.
- Oshima H, Okumura H, Maeda K, Ishijima K, Yoshikawa T, Kurosu T, Fukushi S, Shimojima M, Saijo M. A Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected from a Sick Dog with SFTS Virus Infection. Jpn J Infect Dis. 2022;75(4):423-426.
- Nguyen PHA, Yamada S, Harada S, Fukushi S, Mizuguchi M, Saijo M. Virulence of herpes simplex virus 1 harbouring a UAG stop codon between the first and second initiation codon in the thymidine kinase gene. Jpn J Infect Dis. 2022, Jul 22; 75(4):368-373.
- Shibamura M, Yamada S, Yoshikawa T, Inagaki T, Nguyen P H A, Fujii H, Harada S, Fukushi S, Oka A, Mizuguchi M, Saijo M. Longitudinal trends of neutralizing antibody prevalence against human cytomegalovirus (HCMV) over the past 30 years in Japanese women. Jpn J Infect Dis. 2022, Sep 22;75(5):496-503.
- Saso W, Yamasaki M, Nakakita S I, Fukushi S, Tsuchimoto, K Watanabe N, Sriwilaijaroen N, Kanie O, Muramatsu M, Takahashi Y, Matano T, Takeda M, Suzuki Y, Watashi K. Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2. PLoS Pathog. 2022, Jun14; 18(6):e1010590.
- Kotaki R, Adach Y, Moriyama S, Onodera T, Fukushi S, Nagakura T, Tonouchi K, Terahara K, Sun L, Takano T, Nishiyama A, Shinkai M, Oba K, Nakamura-Uchiyama F, Shimizu H, Suzuki T,Matsumura T, Isogawa M, Takahashi Y. SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine. Sci Immunol. 2022, Apr 22;7(70):eabn8590.
- Ohashi H, Hishiki T, Akazawa D, Kim K S, Woo J, Shionoya K, Tsuchimoto K, Iwanami S, Moriyama S, Kinoshita H, Yamada S, Kuroda Y, Yamamoto T, Kishida N, Watanabe S, Hasegawa H, Ebihara H, Suzuki T, Maeda K, Fukushi S, Takahashi Y, Iwami S, Watashi K. Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2. Antiviral Res. 2022 Sep;205:105372.
- Takashita E, Yamayoshi S, Simon V, van Bakel H, Sordillo E M, Pekosz A, Fukushi S, Suzuki T, Maeda K, Halfmann P, Sakai-Tagawa Y, Ito M, Watanabe S, Imai M, Hasegawa H, Kawaoka Y. Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants. N Engl J Med. 2022 , Aug 4;387(5):468-470 .
- Takashita E, Yamayoshi S, Simon V, van Bakel H, Sordillo E M, Pekosz A, Fukushi S, Suzuki T, Maeda K, Halfmann P, Sakai-Tagawa Y, Ito M, Watanabe S, Imai M, Hasegawa H, Kawaoka Y. Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75. N Engl J Med. 2022 Sep 29;387(13):1236-1238.
- Iwata-Yoshikawa N, Kakizaki M, Shiwa-Sudo N, Okura T, Tahara M, Fukushi S, Maeda K, Kawase M, Asanuma H, Tomita Y, Takayama I, Matsuyama S, Shirato K, Suzuki T, Nagata N, Takeda M. Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways. Nat Commun. 2022 , Oct 15;13(1):6100.
- Uraki R, Halfmann P J, Iida S, Yamayoshi S, Furusawa Y, Kiso M, Ito M, Iwatsuki-Horimoto K, Mine S, Kuroda M, Maemura T, Sakai-Tagawa Y, Ueki H, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Pekosz A, Kandeil A, Webby R J, Wang Z, Imai M, Suzuki T, Kawaoka Y. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents. Nature. 2022 , Dec;612(7940):540-545.
- Seko K, Uchida Y, Kanamori T, Sakurai K, Usami T, Kuno T, Takada K, Nakamichi K, Matsukawa N. Progressive multifocal leukoencephalopathy in multiple myeloma associated with daratumumab, lenalidomide and dexamethasone. Neurol Clin Neurosci 10(3):163-166, 2022
- Negishi N, Ikeguchi R, So H, Kobayashi M, Nitta M, Masui K, Nakamichi K, Takahashi K, Ishida H, Kawamata T, Shibata N, Shimizu Y, Kitagawa K. Successful treatment of progressive multifocal leukoencephalopathy that developed 21 years after renal transplantation: A case report. Neuroimmunol Rep 2:100113, 2022
- Edahiro T, Fukushima N, Otani T, Nakamori M, Nakamichi K, Chishaki R, Fujino K, Mino T, Yoshida T, Sugihara S, Nishizawa M, Ichinohe T. Progressive multifocal leukoencephalopathy in relapsed Ph+ acute lymphoblastic leukemia after cord blood transplantation and blinatumomab treatment: A case report and literature review. Acta Haematol 145(6):655-661, 2022
- Funatsu A, Nakamichi K, Araki M, Fukumoto T, Mine H. Progressive multifocal leukoencephalopathy in a patient with multifocal neurological manifestations caused by solitary brainstem involvement. Intern Med 62:787-792, 2022
- Sugimoto T, Neshige S, Aoki S, Ochi K, Ishikawa R, Nonaka M, Nakamori M, Nezu T, Nakamichi K, Yamazaki Y, Maruyama H. A case of natalizumab-associated progressive multifocal leukoencephalopathy followed by immune reconstitution inflammatory syndrome with difficulty in the timing of immunotherapy. Clin Exp Neuroimmunol 1:1-6, 2022.
- Nagahori T, Shiraishi W, Nishikawa M, Matsuyoshi A, Ogura T, Yamada Y, Takahashi K, Suzuki T, Nakamichi K, Hashimoto T, Hatano T. A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report. BMC Neurol 23(1):52, 2022
- Horiya M, Posadas-Herrera G, Takayama-Ito M, Yamaguchi Y, Iizuka-Shiota I, Kato H, Okamoto A, Saijo M, Lim CK. Genetic Characterization of Human Rabies Vaccine Strain in Japan and Rabies Viruses Related to Vaccine Development from 1940s to 1980s. Viruses. 2022 Sep 29;14(10):2152
- Yamaoka S, Weisend CM, Swenson VA, Ebihara H. Development of accelerated high-throughput antiviral screening systems for emerging orthomyxoviruses. Antiviral Res. 2022 Apr;200:105291.
- Miyamoto S, Arashiro T, Adachi Y, Moriyama S, Kinoshita H, Kanno T, Saito S, Katano H, Iida S, Ainai A, Kotaki R, Yamada S, Kuroda Y, Yamamoto T, Ishijima K, Park ES, Inoue Y, Kaku Y, Tobiume M, Iwata-Yoshikawa N, Shiwa-Sudo N, Tokunaga K, Ozono S, Hemmi T, Ueno A, Kishida N, Watanabe S, Nojima K, Seki Y, Mizukami T, Hasegawa H, Ebihara H, Maeda K, Fukushi S, Takahashi Y, Suzuki T. Vaccination-infection interval determines cross-neutralization potency to SARS- CoV-2 Omicron after breakthrough infection by other variants. Med. 2022 Apr 8;3(4):249-261.e4.
- Wanninger TG, Millian DE, Saldarriaga OA, Maruyama J, Saito T, Reyna RA, Taniguchi S, Arroyave E, Connolly ME, Stevenson HL, Paessler S. Macrophage infection, activation, and histopathological findings in ebolavirus infection. Front Cell Infect Microbiol 12:1023557, 2022
- Intaruck K, Itakura Y, Kishimoto M, Chambaro HM, Setiyono A, Handharyani E, Uemura K, Harima H, Taniguchi S, Saijo M, Kimura T, Orba Y, Sawa H, Sasaki M. Isolation and characterization of an orthoreovirus from Indonesian fruit bats. Virology 575:10-19, 2022
- Reyna RA, Maruyama J, Mantlo EK, Manning JT, Taniguchi S, Makishima T, Lukashevich IS, Paessler S. Depletion of CD4 and CD8 T Cells Reduces Acute Disease and Is Not Associated with Hearing Loss in ML29-Infected STAT1-/- Mice. Biomedicines 10(10):2433, 2022
- Watanabe Y, Suzuki Y, Emi A, Murakawa T, Hishiki T, Kato F, Sakaguchi S, Wu H, Yano T, Lim CK, Takasaki T, Nakano T. Identification of the corticotropin-releasing factor receptor 1 antagonists as inhibitors of Chikungunya virus replication using a Gaussia luciferase–expressing subgenomic replicon. Biochemical and Biophysical Research Communications; 637, 181-188, 2022.
- Matsui K, Yamaya M, Takase M, Morita K, Tajima S, Lim CK, Saijo M, Daibata M, Nagayasu S, Takasaki T. Isolation of genotypes 1 and 3 of Japanese Encephalitis Virus in Kochi, Japan. Jpn J Infect Dis. 2022, 76(2), 151-154,
- Fujii Y, Hirayama M, Nishiyama S, Takahashi T, Okajima M, Izumi F, Takehara K, Masatani T, Sugiyama M, Ito N. Characterization of an avian rotavirus A strain isolated from a velvet scoter (Melanitta fusca): implication for the role of migratory birds in global spread of avian rotaviruses. J Gen Virol, 2022 Feb;103(2).
- Nishiyama S, Hirano M, Muto M, Kambara M, Ito N, Kobayashi S, Kariwa H, Yoshii K. Y-shaped RNA secondary structure of a noncoding region in the genomic RNA of tick-borne encephalitis virus affects pathogenicity. Microbiol Immunol. 2022 Feb 23.
- Kanda M, Fukuda S, Hamada N, Nishiyama S, Masatani T, Fujii Y, Izumi F, Okajima M, Taniguchi K, Sugiyama M, Komoto S, Ito N. Establishment of a Reverse Genetics System for Avian Rotavirus A Strain PO-13. J Gen Virol . 2022 Jun 24;103(6).
- Takahashi T, Inukai M, Izumi F, Fujii Y, Nishiyama S, Masatani T, Sugiyama M, Ito N. Establishment of a Reverse Genetics System for Rabies Virus Strain Komatsugawa. J Vet Med Sci [Internet]. 2022
- Kallu SA, Ndebe J, Qiu Y, Nakao R, Simuunza MC. Prevalence and Association of Trypanosomes and Sodalis glossinidius in Tsetse Flies from the Kafue National Park in Zambia. Trop Med Infect Dis. 8(2):80, 2022
- Su H, Kubo K, Sakabe S, Mizuno S, Komiya N, Akachi S, Fujita H, Sato K, Kawabata H, Nagaoka H, Ando S, Ohashi N. Serologic Evidence of Human Exposure to Ehrlichiosis Agents in Japan. Emerg Infect Dis. 28(11):2355-2357, 2022
- Ogawa M, Takada N, Noda S, Takahashi M, Matsutani M, Kageyama D, Ebihara H. Genetic variation of Leptotrombidium (Acari: Trombicuidae) mites carrying Orientia tsutsugamushi, the bacterial pathogen causing scrub typhus. J Parasitol. (2022)
- YamamotoY, Nakano Y, Murae M, Shimizu Y, Sakai Y, Ogawa M, Mizukami T, Inoue T, Onodera T, Takahashi Y, Wakita T, Fukasawa M, Satoru Miyazaki S, Noguchi K. Direct inhibition of SARS-CoV-2 spike protein by peracetic acid. Int J Mol Sci. (2022)
- Ogawa M, Murae M, Gemba R, Irie T, Shimojima M, Saijo M, Noguchi K, Fukasawa M. L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro. J Infect Chemother. (2022) 28, 373-376.
- Rawle DJ, Le TT, Dumenil T, Bishop C, Yan K, Nakayama E, Bird PI, Suhrbier A. Widespread discrepancy in Nnt genotypes and genetic backgrounds complicates granzyme A and other knockout mouse studies. Elife. 2022 Feb 4;11:e70207.
|